AGL 40.39 Increased By ▲ 0.38 (0.95%)
AIRLINK 127.50 Decreased By ▼ -0.49 (-0.38%)
BOP 6.60 No Change ▼ 0.00 (0%)
CNERGY 4.51 Decreased By ▼ -0.09 (-1.96%)
DCL 8.56 Increased By ▲ 0.08 (0.94%)
DFML 42.26 Increased By ▲ 0.78 (1.88%)
DGKC 87.25 Increased By ▲ 0.67 (0.77%)
FCCL 32.52 Increased By ▲ 0.38 (1.18%)
FFBL 65.21 Decreased By ▼ -0.21 (-0.32%)
FFL 10.23 Decreased By ▼ -0.02 (-0.2%)
HUBC 109.74 Decreased By ▼ -0.75 (-0.68%)
HUMNL 14.57 Decreased By ▼ -0.18 (-1.22%)
KEL 5.12 Decreased By ▼ -0.01 (-0.19%)
KOSM 7.52 Increased By ▲ 0.40 (5.62%)
MLCF 41.60 Decreased By ▼ -0.05 (-0.12%)
NBP 59.54 Decreased By ▼ -0.55 (-0.92%)
OGDC 194.31 Decreased By ▼ -0.38 (-0.2%)
PAEL 28.18 Increased By ▲ 0.23 (0.82%)
PIBTL 7.83 Decreased By ▼ -0.17 (-2.13%)
PPL 152.00 Increased By ▲ 0.83 (0.55%)
PRL 26.56 Decreased By ▼ -0.32 (-1.19%)
PTC 16.06 Increased By ▲ 0.06 (0.38%)
SEARL 82.43 Increased By ▲ 4.23 (5.41%)
TELE 7.50 Increased By ▲ 0.11 (1.49%)
TOMCL 35.30 Decreased By ▼ -0.37 (-1.04%)
TPLP 8.22 Increased By ▲ 0.31 (3.92%)
TREET 16.20 Increased By ▲ 0.31 (1.95%)
TRG 52.75 Decreased By ▼ -0.01 (-0.02%)
UNITY 26.50 Decreased By ▼ -0.05 (-0.19%)
WTL 1.24 Decreased By ▼ -0.03 (-2.36%)
BR100 9,931 Increased By 10.4 (0.1%)
BR30 30,791 Increased By 39.6 (0.13%)
KSE100 93,541 Increased By 316.7 (0.34%)
KSE30 28,987 Increased By 102.1 (0.35%)

Pfizer Inc

Indian shares rise
Markets

Indian shares rise

BENGALURU: Indian shares ended higher on Monday, led by financial and energy stocks, while Pfizer Inc’s local arm...
Published 09 Nov, 2021 04:48am
Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion
Business & Finance

Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion

  • It is expected to make up for more than one-third of Pfizer's full-year sales, with the company in supply talks with several countries for 2022 and beyond.
  • "Based on what we've seen, we believe that a durable demand for our COVID-19 vaccine - similar to that of the flu vaccines - is a likely outcome," Chief Executive Albert Bourla said in his prepared remarks.
Published 04 May, 2021 07:48pm
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU
Business & Finance

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
Published 30 Apr, 2021 04:51pm